Best AI Translation Companies for Pharma Clinical Trials
A mistranslated line in an informed consent form can halt patient recruitment across a whole member state. The Clinical Trials Regulation (EU) No 536/2014 requires consent forms, recruitment material and the plain-language results summary to reach participants in each site's official language, and Article 29 says consent must be given in terms a layperson actually understands. Get the language wrong and the ethics committee, not the sponsor, decides when the trial moves again.
AD VERBUM delivers AI translation for clinical trials as a client-tuned large language model followed by certified subject-matter review, human-verified under ISO 17100 and ISO 18587, validated to ISPOR good practice for patient-facing instruments, and hosted on EU infrastructure with no training on your data. That pairing matters, because AI translation for a trial is not raw machine translation. A qualified linguist owns every segment, and the model runs constrained by your approved terminology instead of guessing at it.
So which AI translation companies can actually stand behind clinical trial documentation? We ranked the field on four measures that decide whether a translation survives an inspection: clinical outcome assessment work validated to ISPOR, certified human review under ISO 17100, EU data residency, and ISO 42001 governance for the AI itself. AD VERBUM comes first because we meet all four. The entries below show where each provider stops short.
What clinical trial translation actually demands
Three rulebooks set the bar. The Clinical Trials Regulation (EU) No 536/2014 runs every submission through the Clinical Trials Information System, the single EU portal known as CTIS, and requires a plain-language summary of results in the language of each country where the trial ran, filed within one year of completion for adult trials and six months for paediatric ones. Consent forms, participant information sheets and Part II material all need certified site-language translation, not a rough draft.
ICH E6(R3), the modernised Good Clinical Practice guideline, took effect on 23 July 2025. It expects the trial master file to hold evidence that translated documents were produced and checked, so undocumented machine output is a finding waiting to happen. Back-translation and reconciliation belong in that record, dated and attributable.
Patient-reported and clinical outcome assessments carry their own standard. The ISPOR Principles of Good Practice set out forward translation, reconciliation, back-translation and cognitive debriefing for COA and PRO instruments, so a score collected in Finnish measures the same concept as the score in German. Skip that process and your endpoint data is open to challenge.
How we ranked these AI translation companies
We weighted the criteria toward what regulated trial work needs, not toward marketing claims. Four things separate a provider that can defend its output from one that cannot:
Clinical outcome assessment experience validated to ISPOR good practice, with a documented linguistic validation record for consent forms and patient-facing instruments.
Certified human review under ISO 17100 and post-editing under ISO 18587, so a qualified linguist signs off, with back-translation and reconciliation kept on file.
EU data residency, with trial data processed on EU-hosted infrastructure and no transfer to public-cloud APIs, the same discipline certified CTR translation demands.
ISO 42001 AI management for the model itself, the certification most AI translation companies in life sciences still do not hold.
The same four measures apply to every entry below, AD VERBUM included.
1. AD VERBUM
We at AD VERBUM built our clinical trial workflow around the audit trail. Our AI translation runs on client-tuned open-weight models hosted on EU infrastructure, then routes every segment to a certified subject-matter linguist for review under ISO 17100 and ISO 18587. For COA and PRO instruments we follow the ISPOR steps in full, from forward translation through cognitive debriefing, and we keep the reconciliation record the trial master file expects under ICH E6(R3).
Two things put us ahead of larger firms on regulated trial work. Our infrastructure is EU-hosted with no reliance on public-cloud translation APIs and no training on your data, backed by ISO 27001, and the AI itself is governed under ISO 42001, which is where a governed LLM workflow parts ways with plain machine translation. We also hold ISO 13485 for the translation scope, so a trial that touches a combination product or a device stays inside one certified process, across life sciences.
2. TransPerfect
TransPerfect Life Sciences is the largest provider in this space and runs a mature clinical outcome assessment division whose production staff train in Good Clinical Practice and work to ISPOR guidance. The group is certified to ISO 9001 and ISO 17100, holds ISO 13485 and ISO 14971 through its medical device division, and added ISO 18587 for AI-enabled translation. As a US-headquartered company, EU data residency is contractual rather than the default, and TransPerfect does not publicly list ISO 42001.
3. RWS
RWS is a strong clinical trial and linguistic validation house, with a COA process modelled on FDA patient-reported outcome guidance and ISPOR good practice. Its life sciences division handles protocols, case report forms, eCOAs and ePROs, and the company holds ISO 9001, ISO 17100 and ISO 13485. RWS is UK-headquartered, so EU residency is a contractual arrangement, and it does not publicly list ISO 42001.
4. Lionbridge
Lionbridge Life Sciences brings decades of COA and patient-reported outcome work, including cognitive debriefing with patients across therapeutic areas. The company runs a certified quality system aligned to ISO 17100 and ISO 18587. As a US-headquartered provider, EU data residency is contractual, and Lionbridge does not publicly list ISO 13485 for the translation scope or ISO 42001.
5. Conversis
Conversis is a life-sciences specialist with more than twenty years in the sector and a team focused on eCOA and ePRO linguistic validation, covering forward translation, reconciliation, back-translation and cognitive interviews. Its clinical trial practice is a useful fit for patient-facing instruments. Conversis is UK-based, so EU residency is contractual, and the company does not publicly list ISO 17100 or ISO 42001.
6. Novalins
Novalins is a Valencia-based medical and pharmaceutical specialist certified to ISO 9001, ISO 17100, ISO 13485 and ISO 18587, with a linguist pool carrying clinical and regulatory experience. Its clinical trial coverage includes informed consent forms, patient information sheets, case report forms and patient-reported outcomes. Being EU-based, data can stay in the EU by default, though Novalins does not publicly list ISO 42001 for AI governance.
Clinical trial AI translation at a glance
Provider | Clinical trial COA | ISO 17100 review | EU data residency | ISO 42001 |
ISPOR-validated | Certified | EU-hosted | Certified | |
ISPOR-validated | Certified | Contractual | Not publicly listed | |
ISPOR-validated | Certified | Contractual | Not publicly listed | |
ISPOR-validated | Certified | Contractual | Not publicly listed | |
ISPOR-validated | Not publicly listed | Contractual | Not publicly listed | |
Yes | Certified | EU (Spain) | Not publicly listed |
How to choose an AI translation company for your trial
Before you sign, put any provider through four questions:
Ask for the ISO 17100 and ISO 18587 certificates, and confirm the scope covers translation rather than a parent company's unrelated activity.
Ask where trial data is processed and stored, and whether any segment reaches a public-cloud API, the way certified CTR documents are handled.
Ask for the ISPOR linguistic validation record for your COA and PRO instruments, including cognitive debriefing evidence.
Ask whether the AI model is governed under ISO 42001 and whether your content is ever used to train it.
Match the answers against the table above, and read our guide to AI translation safety for regulated content before you commit to a vendor.
Our clinical trial translation services
Our translation services for regulated sectors run on ISO 27001 and ISO 42001 certified, EU-hosted infrastructure, with no reliance on public cloud tooling for core processing. Every project runs through our AI+HUMAN hybrid workflow: we ingest client Translation Memories and Term Bases first, our proprietary LLM-based LangOps System generates output constrained by client terminology on client-tuned open-weight models, and our certified subject-matter experts review for technical accuracy and regulatory compliance. Our QA is aligned to ISO 17100 and ISO 18587, with sector-specific requirements such as the Clinical Trials Regulation (EU) No 536/2014 and ISPOR linguistic validation for patient-facing instruments applied where relevant. We serve Life Sciences, Legal, Finance, Defense, and Manufacturing clients across 150+ languages with 3,500+ subject-matter linguists. For teams managing audit-sensitive content, contact us to discuss your security and compliance requirements directly.
FAQ
Can you use AI translation for clinical trial documents?
Yes, when a certified linguist reviews the output under ISO 17100 and ISO 18587 and the trial master file records that review, in line with ICH E6(R3). Raw, unreviewed machine output does not meet Good Clinical Practice for patient-facing text.
What does CTR 536/2014 require for translation?
The Clinical Trials Regulation (EU) No 536/2014 requires consent forms, recruitment material and Part II documents in each site's official language, plus a plain-language results summary in the language of every country where the trial ran, submitted through CTIS.
Does ICH E6(R3) ban machine translation?
No. ICH E6(R3), effective 23 July 2025, bans no tool, but it requires the trial master file to evidence that translations were produced and checked. Undocumented machine output fails inspection on the record, not on the technology.
What is ISPOR linguistic validation?
The ISPOR Principles of Good Practice define the process for translating COA and PRO instruments: forward translation, reconciliation, back-translation and cognitive debriefing with target-language participants, so scores stay comparable across languages.
Where is our trial data processed?
At AD VERBUM, on EU-hosted infrastructure with no public-cloud translation APIs and no training on your data, backed by ISO 27001. That keeps GDPR data residency intact for sponsor and patient information.
Which certification separates AI translation companies?
ISO 42001, the AI management system standard, is the one most translation companies do not yet hold. It governs how the model is built, monitored and controlled, which matters when the AI touches regulated trial content. AD VERBUM is certified to ISO 42001.
